they (NR) imo barely did 10 day volume maintenance today

New Post Public Reply Private Reply Replies (1) Message Board

Aug 27, 2018 at 5:27 PM 295

they (NR) *imo* barely did 10 day volume maintenance today on IPIX

Detailed Quote:IPIX .. goes off hidden
INNOVATION PHARMACEUTICALS INC
0.39625Down -0.02375 (-5.65 %)AS OF 3:57:47PM ET 08/27/2018

Last Trade 0.39625
Trade Time 3:57:47pm ET

Change -0.02375
% Change -5.65%

Bid 0.385
Bid Size 5700

Ask 0.40
Ask Size 3000

Open 0.4025
Day High 0.42 ** .0367c *liquidity*
Day Low 0.3833
Previous Close
08/24/2018 0.42
52-Week High
12/06/2017 1.17
52-Week Low
06/21/2018 0.325

Price Performance (Last 52 Weeks)
08/24/2018 -41.98%

Volume 111,105
Volume (10 day Average) 103,183
Volume (90 day Average) 204,551

Market Capitalization $74.00M
Shares Outstanding 176,200,000

last grab B/A .. may not align with Fido's above ..



ETRF	0.385	3,000	15:52 

CDEL	0.385	2,700	15:34 

NITE	0.3833	2,500	14:32 

CSTI	0.3823	2,500	14:30 

CANT	0.36	2,500	08:30 

LAFC	0.3526	2,500	08/13 

STXG	0.30	2,500	04/17 

VERT	0.30	2,500	08/07 

VNDM	0.30	2,500	08/24 

PUMA	0.30	2,500	08:10 

MAXM	0.0001	10,000	08/24 

DBOX	U	0	04/16 

STFL	U	0	08/24 

OTCX	U	0	10:41 

 

LAFC	0.40	3,000	12:45 

CDEL	0.41	10,000	15:34 

NITE	0.41	2,500	15:19 

ETRF	0.43	4,000	14:32 

CSTI	0.43	2,500	08:30 

PUMA	0.46	2,500	08:10 

CANT	0.468	2,500	08:30 

VERT	0.60	1,000	08/02 

VNDM	0.64	1,000	08/24 

STXG	2.00	100	10/05 

MAXM	8.00	100	08/24 

DBOX	U	0	04/16 

STFL	U	0	08/24 

OTCX	U	0	09:34

8.27.18 .. IPIX trades



15:57:47		0.39625	5000	OTO .. last trade goes off hidden like many did 

15:51:05		0.3995	100	OTO 

15:51:05		0.39625	100	OTO 

15:34:46		0.385	250	OTO 

15:33:32		0.385	1000	OTO 

15:20:29		0.385	2500	OTO 

15:20:25		0.3925	2500	OTO 

15:20:22		0.397	2350	OTO 

15:15:30		0.397	400	OTO 

15:14:44		0.397	300	OTO 

15:10:47		0.391	100	OTO 

15:00:31		0.387	50	OTO 

14:57:08		0.3945	100	OTO 

14:55:08		0.387	2500	OTO 

14:32:08		0.3833	4028	OTO 

14:32:05		0.388	3472	OTO 

14:31:42		0.3925	2500	OTO 

14:30:48		0.39	13100	OTO 

14:30:40		0.39	3500	OTO 

14:29:38		0.39	4500	OTO 

13:59:03		0.39	3000	OTO 

13:19:33		0.3975	2500	OTO 

12:45:50		0.40	1000	OTO 

12:45:31		0.39	900	OTO 

12:45:11		0.39	100	OTO 

12:41:45		0.39	4000	OTO 

12:41:23		0.39	8600	OTO 

12:40:49		0.39025	2400	OTO 

12:22:39		0.40	750	OTO 

12:02:34		0.405	155	OTO 

11:56:24		0.4095	165	OTO 

11:56:24		0.405	165	OTO 

11:48:37		0.40	3000	OTO 

11:48:00		0.40	1000	OTO 

11:43:19		0.391	50	OTO 

11:39:30		0.39	300	OTO 

11:39:30		0.3925	2640	OTO 

11:17:06		0.40	100	OTO 

11:16:36		0.40	100	OTO 

11:16:06		0.40	100	OTO 

11:15:36		0.40	100	OTO 

11:15:06		0.40	100	OTO 

11:14:36		0.40	100	OTO 

11:14:06		0.40	100	OTO 

11:13:36		0.40	100	OTO 

11:13:06		0.40	100	OTO 

11:12:36		0.40	100	OTO 

11:06:04		0.40	500	OTO 

10:54:58		0.40	400	OTO 

10:54:58		0.40125	1860	OTO 

10:41:28		0.4011	2050	OTO 

10:40:01		0.41	900	OTO 

10:39:55		0.41	2500	OTO 

10:39:45		0.41	100	OTO 

10:30:47		0.41	1900	OTO 

10:30:41		0.41	100	OTO 

10:30:06		0.41	5000	OTO 

10:03:35		0.40	100	OTO 

10:03:35		0.4006	5000	OTO 

09:44:03		0.41	2600	OTO 

09:44:03		0.4125	5000	OTO 

09:34:56		0.42	700	OTO 

09:32:43		0.405	2000	OTO 

09:30:04		0.4025	300	OTO 

09:30:00		0.385	20	OTO

4kids

Quote:

And here we go with the return of soft bashing. The ovarian cancer trial did not "stop abruptly," it concluded and the company said that it was putting its funds toward the clinical trials that could be concluded quickly and relatively cheaply. Had the company decided to spend the next 5 years focusing on a cancer trial, instead of bringing some Brilacidin formulations and Prurisol to clinical trials, THEN people would have something to complain about.

But claiming that a clinical trial "abruptly stopped" implies that there was something wrong with the drug. There was NOT. There was just a shortage of money to run a lengthy, expensive trial that would have results only a long time in the future.

Perfect example of soft bashing: "I'm a bull but boy is this a red flag..."

"They" must be getting really worried, to resort to this level of BS aimed at a crowd of knowledgeable investors, who call BS when they see it.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Munters Updates Financial Targets Amid Growth Plans

Munters' Bold New Targets and Strategic Moves Ever feel like you're on a constant treadmill chasing numbers? Munters Group knows the feeling. Over in Stockholm, they've just laid out fresh strategies at their Capital Markets Day—not just any pie-in-the-sky type goals, but heavy hitters that are setting the tone for their future. CEO Stefan Aspman is all geared up,...

Pharmacy Credentials Gain Importance in Delaware Law

Credentialing Takes Front Seat in Pharmacy World Well, hold onto your hats because the pharmacy profession is getting a major upgrade, particularly if you're an investor watching healthcare regulation. The American Association of Colleges of Pharmacy (AACP) has thrown its support behind professional credentialing for pharmacists, which is a big deal, trust me. Pharmacy...

Epson Unveils Early Black Friday Tech Deals

Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...

CodeROI Automates AI Cost Tracking for Capitalization

Revolutionizing Software Capitalization with CodeROI Forget the good old days when estimating software costs was like pinning the tail on a moving donkey. CodeROI’s latest brainchild brings a sorely needed tune-up, integrating AI development costs into software capitalization. And just in the nick of time, with FASB’s upcoming rule change looming over every tech-savvy...

QFIN Lawsuit: Executives Face Control Liability

QFIN Executives in Legal Hot Water Qfin Holdings, Inc. (NASDAQ: QFIN) is in a tight spot as a securities class action lawsuit casts a harsh spotlight on its senior executives. The CEO and CFO, during the contested class period, are front and center in this legal tangle. Qfin's stockholders are grappling with losses, and it's all tied back to some certified SEC filings...

IMG's 2026 Grants Fuel Global Community Impact

Celebrating a Milestone: IMG's Grant Success In a world often tangled with red tape and bureaucracies, here's a clean shot of hope: IMG, aka International Medical Group, just dished out some well-earned greenbacks to groups making meaningful ripples. This year, they've upped their game by bestowing $3,500 each to Footsteps Bangladesh and Hope Ministries Uganda. Tuck those...

Innovative Storm Protection System for New Homes Unveiled

A Fresh Approach to Storm Preparedness Natural disasters don't give you the luxury of foresight—they just roll in uninvited, leaving chaos in their wake. Now, here's a tale of someone who's taken matters into his own hands. This tinkerer from Los Angeles scratched his head long enough and came up with what he's calling the 'MENDEZ INVENTION.' A contrivance aimed at...

Goranson Bain Ausley Welcomes Marichalar: Family Law Focus

Strengthening San Antonio's Family Law Field Brenda Marichalar is joining the ranks at Goranson Bain Ausley (GBA) with a reputation built on solid courtroom chops and a knack for making clients feel like they’re more than just case numbers. She’s landing right in San Antonio, a region that’s not just about the riverwalks and missions, but about real families...

Eli Lilly's Taltz and Zepbound Deliver Promising Results

Game-Changing Results for Psoriatic Arthritis Surprising everyone this side of the stock ticker, Eli Lilly (NYSE: LLY) just announced their new data: pairing Taltz (ixekizumab) with Zepbound brought a clinical revolution for folks battling psoriatic arthritis and obesity. It's like finding gold under your mat—a combo punching PsA better than Taltz going solo. AT 52...

Helix Raises $6.2M, Tackles AI Fraud with Voice Tech

A New Era of Voice-Driven Verification Blockchain and biometrics? Ancient history. Today, Helix drops a game-changer into the digital verification scene, raising a hefty $6.2 million in pre-seed capital. They're tackling the AI age's rampant bot issues with some slick voice-based magic. Imagine biometric-level security from a four-second challenge—not a bad little trick...